A patient-centered approach is recommended to tailor to individual needs when calculating individual protein needs.

In the CONVERT trial 830 maintenance renal allograft recipients (6–120 months post-transplant ... 20–40 ml/min and in patients with baseline proteinuria. Worsening proteinuria among patients ...

LYSOZYME, a bacteriolytic enzyme discovered in 1922 by Sir Alexander Fleming, 2 is found in a number of biologic fluids. The enzyme is a basic protein of low molecular weight that lyses ...

Complete renal response included a urinary protein-to-creatinine ratio (UPCR) of less than 0.5 mg/mg and a stable estimated glomerular filtration rate (eGFR) at least 85% of the baseline value ...

Albuminuria and proteinuria predict increased risk of cardiovascular and renal end points in patients with diabetic or nondiabetic kidney disease. [40,41] Clinical trials have found that reduction ...

We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...